Bxrx News Today

Baudax Bio (NASDAQ:BXRX – Get Free Report) is scheduled to post its quarterly earnings results on Wednesday, February 21st. Baudax Bio (NASDAQ:BXRX – Get Free Report) last announced its quarterly earnings results on Monday, November 20th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.53) by $0.24. On average, analysts […]

Baudax Bio (NASDAQ:BXRX – Get Free Report) issued its earnings results on Monday. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($0.53) by $0.24, reports. Baudax Bio Stock Down 10.0 % Baudax Bio stock traded down $0.01 during mid-day trading on Thursday, hitting $0.06. 344,225 shares of the company were […]

By Chris Wack Baudax Bio shares doubled to 67 cents after the company said that U.S. Food and Drug Administration has granted orphan drug designation to its...

Baudax Bio, Inc. (NASDAQ:BXRX – Get Free Report) was the recipient of a significant drop in short interest in August. As of August 15th, there was short interest totalling 142,700 shares, a drop of 27.8% from the July 31st total of 197,700 shares. Approximately 1.7% of the company’s shares are short sold. Based on an […]

Baudax Bio, Inc. (NASDAQ:BXRX – Get Free Report) was the target of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 142,700 shares, a decrease of 27.8% from the July 31st total of 197,700 shares. Currently, 1.7% of the shares of the stock are […]

Baudax Bio (NASDAQ:BXRX – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($1.49) EPS for the quarter, beating the consensus estimate of ($2.04) by $0.55, MarketWatch Earnings reports. Baudax Bio Stock Performance BXRX opened at $0.52 on Friday. The business has a 50-day moving average of $0.69 and a two-hundred […]

Baudax Bio (NASDAQ:BXRX – Get Free Report) posted its earnings results on Wednesday. The company reported ($1.49) EPS for the quarter, topping analysts’ consensus estimates of ($2.04) by $0.55, MarketWatch Earnings reports. Baudax Bio Stock Down 5.2 % NASDAQ:BXRX traded down $0.03 during midday trading on Thursday, hitting $0.53. The stock had a trading volume […]

Baudax Bio (NASDAQ:BXRX – Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($1.49) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.04) by $0.55, MarketWatch Earnings reports. Baudax Bio Stock Performance NASDAQ BXRX traded down $0.03 during trading hours on Thursday, hitting $0.53. The company had […]

Baudax Bio, Inc. (NASDAQ:BXRX – Get Free Report) was the target of a large decline in short interest in the month of July. As of July 31st, there was short interest totalling 197,700 shares, a decline of 50.1% from the July 15th total of 396,100 shares. Based on an average trading volume of 2,150,000 shares, […]

Baudax Bio, Inc. (NASDAQ:BXRX – Get Free Report) saw a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 197,700 shares, a drop of 50.1% from the July 15th total of 396,100 shares. Currently, 2.8% of the shares of the company are short sold. Based […]